openPR Logo
Press release

Von Willebrand Disease Treatment Market To Reach Valuation Of ~US$ 900 Mn By 2030

02-16-2022 01:49 PM CET | Health & Medicine

Press release from: Transparency Market Research

Von Willebrand Disease Treatment Market

Von Willebrand Disease Treatment Market

Von Willebrand Disease Treatment Market: Introduction
According to the report, the global von Willebrand disease treatment market was valued at US$ 471.1 Mn in 2019 and is projected to expand at a CAGR of ~6% from 2020 to 2030. Von Willebrand disease is an inherited bleeding disorder caused due to deficiency or dysfunction of von Willebrand factor (VWF). Moreover, genetic mutation is one of the causes of von Willebrand disease. Defects or deficiency of VWF can cause bleeding by impairing platelet adhesion or by reducing the concentration of FVIII. Various treatment options are available for the treatment of von Willebrand disease, including desmopressin, clot-stabilizing medications, replacement therapies, and contraceptives. The expansion of the global von Willebrand disease treatment market can be ascribed to an increase in number of patient assistance programs and the demand for recombinant therapies.

Read Report Overview - https://www.transparencymarketresearch.com/von-willebrand-disease-treatment-market.html

North America dominated the global von Willebrand disease treatment market in 2019. This trend is anticipated to continue during the forecast period. A highly structured healthcare industry and increase in incidence of disease are likely to boost the market in North America. Furthermore, the presence of major market players, who focusing on design and development of new treatment option for treatment of von Willebrand disease, is likely to drive the market in North America. Asia Pacific is likely to be a highly lucrative region of the global von Willebrand disease treatment market. It is projected to expand at a rapid pace during the forecast period.

Request Sample of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=57729

Government Initiatives and Rise in Demand for Recombinant Therapies to Drive Global Von Willebrand Disease Treatment Market
Von Willebrand disease is a rare disease and needs government support in terms of research funding, treatment centers, and spreading awareness among people about the disease. Hence, governments of several countries and government organizations have turned focus toward this bleeding disorder. Recombinant VWF (genetically engineered von Willebrand factor product) is gaining popularity due to advantages over replacement therapy such as less chance of allergic reaction, viral infection, and less risk of disease transmission. The increase in use of recombinant therapy is projected to boost the global von Willebrand disease treatment market. Strong product pipeline and increase in the number of patient assistance programs are also anticipated to propel the global von Willebrand disease treatment market during the forecast period.

Request for Covid-19 Impact Analysis - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=57729

Type 1 Von Willebrand Disease to Dominate Global Market
Based on disease type, the global von Willebrand disease treatment market has been divided into type 1 von Willebrand disease, type 2 von Willebrand disease, type 3 von Willebrand disease, and acquired von Willebrand disease. The type 1 von Willebrand disease segment dominated the global von Willebrand disease treatment market in 2019. This trend is projected to continue during the forecast period. The rise in the number of VWD cases, technological advancements, and new product launches contributed to the significant share held by the segment in 2019. Moreover, increase in patient pool for type 1 disease-Type 1 VWD accounts for 60% to 80% of the patients with VWD-is likely to drive the segment.
The type 2 von Willebrand disease segment was followed by the type 1 von Willebrand disease segment, in terms of market share, in 2019. Increasing patient pool for different type 2 VWD, i.e. type 2A, type 2B, type 2M, and type 2N, is likely to drive the segment.
Desmopressin to be Highly Lucrative Segment of Von Willebrand Disease Treatment Market
In terms of drug, the global von Willebrand disease treatment market has been segregated into desmopressin, clot-stabilizing medications, replacement therapies, contraceptives, and others. The desmopressin segment accounted for a prominent share of the global von Willebrand disease treatment market in 2019, owing to high effectiveness in the treatment of the disease. Desmopressin is first line of treatment for von Willebrand disease. Increasing use of desmopressin in the treatment of VWD is likely to drive the segment.

Enquiry Before Buying - https://www.transparencymarketresearch.com/sample/sample.php?flag=EB&rep_id=57729

Injection Segment Accounted for Major Share of Global Market
In terms of route of administration, the global von Willebrand disease treatment market has been categorized into oral, injection, and others. The injection segment dominated the global von Willebrand disease treatment market, in terms of revenue, in 2019. The trend is expected to continue during the forecast period. Factors such as easy, convenient route of administration of drugs, and availability of most treatment products in injection form are likely to drive the injection segment.

Women to be Key Lucrative Segment of Von Willebrand Disease Treatment Market
In terms of gender, the global von Willebrand disease treatment market has been categorized into men and women. The women segment dominated the global von Willebrand disease treatment market, in terms of revenue, in 2019. Increasing incidence of bleeding disorders such as VWD and menorrhagia in women is likely to fuel the segment.

Hospital Pharmacies to be Major Distribution Market
In terms of distribution channel, the global von Willebrand disease treatment market has been classified into hospital pharmacies, retail pharmacies, and online pharmacies. The hospital pharmacies segment led the global von Willebrand disease treatment market in terms of revenue in 2019. The trend is expected to continue during the forecast period. Rapid increase in the number of hospitals and a wide range of services available in multispecialty hospitals are likely to boost the segment during the forecast period. The retail pharmacies segment is witnessing expansion, as medicines for von Willebrand disorders are advised for longer period, which prompts patients to prefer retail stores instead of a visit to the hospitals.

North America to Dominate Von Willebrand Disease Treatment Market
In terms of region, the global von Willebrand disease treatment market has been split into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global von Willebrand disease treatment market in 2019. It was followed by Europe. Significant share held by North America can be ascribed to the presence of players with significant research and development activities in order to develop new products for the treatment VWD. Moreover, a rise in prevalence of VWD is anticipated to fuel the von Willebrand diseases treatment market in the region. According to the National Hemophilia Foundation, around 1% of the U.S. population suffers from VWD.
The von Willebrand disease treatment market in Asia Pacific is anticipated to expand at a rapid pace from 2020 to 2030. The increase in opportunities to launch new products and a surge in the demand for new treatment options are key factors that are expected to boost the von Willebrand disease treatment market in Asia Pacific.

Competition Landscape of Von Willebrand Disease Treatment Market
The global von Willebrand disease treatment market is fragmented in terms of number of players. Key players operating in the global market include Octapharma AG, Grifols, S.A., Shire plc, Bayer AG, CSL Behring, Pfizer, Inc., Akorn, Inc., and Ferring B.V.

More Trending Reports by Transparency Market Research:

Hepatitis E Diagnostic Tests Market: https://www.prnewswire.com/news-releases/hepatitis-e-diagnostic-tests-market-to-rise-at-cagr-of-4-5-during-forecast-period-notes-tmr-study-301472302.html

Human Microbiome Market: https://www.prnewswire.com/news-releases/human-microbiome-market-to-reach-us-2-2-bn-by-2028--states-tmr-report-301475663.html

Triclabendazole Market: https://www.prnewswire.com/news-releases/increase-in-prevalence-of-fascioliasis-to-help-triclabendazole-market-reach-us-632-1-mn-by-2031--notes-tmr-study-301478857.html

About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. 
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports. 

Contact
Mr. Rohit Bhisey
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Von Willebrand Disease Treatment Market To Reach Valuation Of ~US$ 900 Mn By 2030 here

News-ID: 2554658 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for Willebrand

Von Willebrand Disease Treatment Market Statistical Forecast, Trade Analysis 202 …
DataM Intelligence has published a new research report on "Von Willebrand Disease Treatment Market Size 2024". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status. Get a Free Sample Research
Von Willebrand Disease Treatment Market Size 2024 to 2031.
Market Overview and Report Coverage Von Willebrand Disease is a rare inherited bleeding disorder that affects the blood's ability to clot properly. The Von Willebrand Disease Treatment Market encompasses medications, blood transfusions, and other therapies aimed at managing the symptoms and improving the quality of life for patients with this condition. The future outlook for the Von Willebrand Disease Treatment Market is promising, with a projected growth at a CAGR
Acquired von Willebrand Disease (AvWD) Treatment Market Size, Analysis And Forec …
Acquired von Willebrand syndrome is a highly heterogeneous bleeding disorder, that usually displays mild to moderate hemorrhagic symptoms that may at times be severe too. Many a time the severity increases post-surgery. AvWS is considered a rare disorder, however, the actual prevalence is not as rare. In case the laboratory findings diagnose vWD in a patient with no family history, AvWS-associated conditions are usually explored. The acquired von Willebrand disease
Norway Von Willebrand Disease Treatment Market Trends, Current Demand, and Busin …
According to a Transparency Market Research (TMR) research report, the global von willebrand disease treatment market is expected to reach ~US$ 900 Mn by the end of 2030. This suggests that the market is likely to expand at a CAGR of ~6% during the forecast period, 2020 to 2030. The business intelligence study on the market is prepared by employing industry-validated primary and secondary methods. The study uses these to collect
Growing Healthcare Expenditure Lead To Extensive Sales In Von Willebrand Disease …
The Fact.MR report offers insight into the Competitive Dynamic in Von Willebrand Disease Treatment Market which has shaped the major strategies of each player. It also covers recent moves such as partnerships and collaborations, mergers and acquisitions, diversification and research investments, of each prominent player. The key factors that shape the entry barrier and intensity of competition in the Von Willebrand Disease Treatment market are presented in the analysis. Further, the
05-11-2021 | Health & Medicine
Fact.MR
Von Willebrand disease treatment therapies and Von Willebrand Disease treatment …
The research report presents a comprehensive assessment of the Von Willebrand Disease Treatment Market and contains thoughtful insights, facts, historical data and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to market segments such as geographies, application and industry To remain ‘ahead’ of your competitors, request for a sample - https://www.factmr.com/connectus/sample?flag=S&rep_id=1496 Von Willebrand Disease